Concepedia

Helen Partridge

HP

8

Publications

858

Citations

8

H-Index

2011

Active since

Affiliations

Toronto General Hospital(Current)

University of Toronto

Royal Bournemouth Hospital

Fred Hutch Cancer Center

Boehringer Ingelheim (United States)

Helen Partridge is an author at Toronto General Hospital specializing in attention control, psychiatry, and diabetes.

ORCID

Top concepts

Publications per year

2011–2020

8

Publications

8

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

Frits van Rhee, Peter M. Voorhees, Angela Dispenzieri et al. · Blood · 2018 · 394 citations · Full text

Sodium-Glucose Cotransporter 2 Inhibition and Glycemic Control in Type 1 Diabetes: Results of an 8-Week Open-Label Proof-of-Concept Trial

Bruce A. Perkins, David Z.I. Cherney, Helen Partridge et al. · Diabetes Care · 2014 · 228 citations · Full text

Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6 blockade–refractory idiopathic multicentric Castleman disease

David C. Fajgenbaum, Ruth-Anne Langan, Alberto Sada Japp et al. · Journal of Clinical Investigation · 2019 · 134 citations · Full text

Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes

Bruce A. Perkins, David Z.I. Cherney, Nima Soleymanlou et al. · PLoS ONE · 2015 · 31 citations · Full text

HbA<sub>1c</sub> 3 months after diagnosis predicts premature mortality in patients with new onset type 2 diabetes

David Kerr, Helen Partridge, J. Eugene Knott et al. · Diabetic Medicine · 2011 · 21 citations · Full text

Rows per page

1–5 of 8